October 25, 2026

Chemotherapy and Targeted Therapy

Strategic Leadership Shift: AAPS Appoints Dr. Patrick J. Sinko as Chief Science Officer strategic-leadership-shift-aaps-appoints-dr-patrick-j-sinko-as-chief-science-officer

Strategic Leadership Shift: AAPS Appoints Dr. Patrick J. Sinko as Chief Science Officer

Laily UPN October 16, 2026
The American Association of Pharmaceutical Scientists (AAPS)—a preeminent professional body representing over 7,000 scientists, educators, and regulatory...
Read More Read more about Strategic Leadership Shift: AAPS Appoints Dr. Patrick J. Sinko as Chief Science Officer
A Visionary Appointment: Patrick J. Sinko Named Chief Science Officer of the American Association of Pharmaceutical Scientists a-visionary-appointment-patrick-j-sinko-named-chief-science-officer-of-the-american-association-of-pharmaceutical-scientists

A Visionary Appointment: Patrick J. Sinko Named Chief Science Officer of the American Association of Pharmaceutical Scientists

Sagoh October 15, 2026
The American Association of Pharmaceutical Scientists (AAPS) has announced the appointment of Dr. Patrick J. Sinko, Ph.D.,...
Read More Read more about A Visionary Appointment: Patrick J. Sinko Named Chief Science Officer of the American Association of Pharmaceutical Scientists
The AI Drug Discovery Gold Rush: Iambic Therapeutics Debuts on Nasdaq with $150 Million IPO the-ai-drug-discovery-gold-rush-iambic-therapeutics-debuts-on-nasdaq-with-150-million-ipo

The AI Drug Discovery Gold Rush: Iambic Therapeutics Debuts on Nasdaq with $150 Million IPO

Laily UPN October 15, 2026
In a landmark moment for the burgeoning intersection of artificial intelligence and biotechnology, Iambic Therapeutics has successfully...
Read More Read more about The AI Drug Discovery Gold Rush: Iambic Therapeutics Debuts on Nasdaq with $150 Million IPO
A New Frontier in Neuroscience: Arrowhead’s RNAi Breakthrough Targets the Root of Neurodegeneration a-new-frontier-in-neuroscience-arrowheads-rnai-breakthrough-targets-the-root-of-neurodegeneration

A New Frontier in Neuroscience: Arrowhead’s RNAi Breakthrough Targets the Root of Neurodegeneration

Suro Senen October 14, 2026
In a landmark development for the field of neurology, pharmaceutical firm Arrowhead Pharmaceuticals has achieved a milestone...
Read More Read more about A New Frontier in Neuroscience: Arrowhead’s RNAi Breakthrough Targets the Root of Neurodegeneration
AAPS Appoints Pharmaceutical Veteran Dr. Patrick J. Sinko as Chief Science Officer to Drive Scientific Innovation aaps-appoints-pharmaceutical-veteran-dr-patrick-j-sinko-as-chief-science-officer-to-drive-scientific-innovation

AAPS Appoints Pharmaceutical Veteran Dr. Patrick J. Sinko as Chief Science Officer to Drive Scientific Innovation

Lina Hope October 14, 2026
The American Association of Pharmaceutical Scientists (AAPS), a global non-profit organization representing more than 7,000 scientists and...
Read More Read more about AAPS Appoints Pharmaceutical Veteran Dr. Patrick J. Sinko as Chief Science Officer to Drive Scientific Innovation

You may have missed

unraveling-the-colorectal-cancer-paradox-msk-researchers-discover-dual-roles-of-immune-cells-paving-way-for-new-therapies

Unraveling the Colorectal Cancer Paradox: MSK Researchers Discover Dual Roles of Immune Cells, Paving Way for New Therapies

Azzam Bilal Chamdy October 25, 2026
new-evidence-shows-depression-linked-to-circadian-rhythm

New evidence shows depression linked to circadian rhythm

Nana Muazin October 25, 2026
a-storm-of-resilience-brenjas-journey-through-triple-negative-breast-cancer

A Storm of Resilience: Brenja’s Journey Through Triple-Negative Breast Cancer

Azzam Bilal Chamdy October 25, 2026
bridging-the-gap-metavivors-2026-legislative-strategy-and-the-push-for-metastatic-breast-cancer-research-reform

Bridging the Gap: METAvivor’s 2026 Legislative Strategy and the Push for Metastatic Breast Cancer Research Reform

Dwi Wanna October 25, 2026